CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Yi Bao(Stevens Institute of Technology), Arul M. Chinnaiyan(Howard Hughes Medical Institute)
Cited by 6
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
|Cancer Discovery|2017|422
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
|Journal of Clinical Investigation|2018|209